Maria Düring

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Michael A. Nauck, Anders Frid, Kjeld Hermansen et al. · Diabetes Care · 2008 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

Johan Jendle, Michael A. Nauck, David R. Matthews et al. · Diabetes Obesity and Metabolism · 2009 · 304 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol

M Blichert-Toft, Maja Nielsen, Maria Düring et al. · Acta Oncologica · 2008 · 297 citations · Full text

Medicine, Oncology, Surgery +15

Prognostic effect of estrogen receptor status across age in primary breast cancer

N Bentzon, Maria Düring, Birgitte Rasmussen et al. · International Journal of Cancer · 2007 · 162 citations · Full text

Medicine, Endocrinology, Oncology +16

Liraglutide suppresses postprandial triglyceride and apolipoprotein <scp>B48</scp> elevations after a fat‐rich meal in patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, cross‐over trial

Kjeld Hermansen, Tine A. Bækdal, Maria Düring et al. · Diabetes Obesity and Metabolism · 2013 · 142 citations · Full text

Medicine, Endocrinology, Pharmacology +17